These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 24923384)
1. Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study. Goutelle S; Sidolle E; Ducher M; Caron J; Timour Q; Nony P; Gouraud A Drugs Aging; 2014 Aug; 31(8):601-9. PubMed ID: 24923384 [TBL] [Abstract][Full Text] [Related]
2. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome. Darbar D; Kimbrough J; Jawaid A; McCray R; Ritchie MD; Roden DM J Am Coll Cardiol; 2008 Feb; 51(8):836-42. PubMed ID: 18294569 [TBL] [Abstract][Full Text] [Related]
3. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study. Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C; Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476 [TBL] [Abstract][Full Text] [Related]
5. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. Kirchhof P; Franz MR; Bardai A; Wilde AM J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731 [TBL] [Abstract][Full Text] [Related]
6. High prevalence of risk factors in elderly patients using drugs associated with acquired torsades de pointes chronically in Colombia. Moreno-Gutiérrez PA; Gaviria-Mendoza A; Cañón MM; Machado-Alba JE Br J Clin Pharmacol; 2016 Aug; 82(2):504-11. PubMed ID: 27060989 [TBL] [Abstract][Full Text] [Related]
7. Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France. Molokhia M; Pathak A; Lapeyre-Mestre M; Caturla L; Montastruc JL; ; McKeigue P Br J Clin Pharmacol; 2008 Sep; 66(3):386-95. PubMed ID: 18637888 [TBL] [Abstract][Full Text] [Related]
8. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713 [TBL] [Abstract][Full Text] [Related]
9. A case series of drug-induced long QT syndrome and Torsade de Pointes. Tong KL; Lau YS; Teo WS Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578 [TBL] [Abstract][Full Text] [Related]
10. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes. Jackobson G; Carmel NN; Lotan D; Kremer A; Justo D Z Gerontol Geriatr; 2018 Jan; 51(1):41-47. PubMed ID: 27878411 [TBL] [Abstract][Full Text] [Related]
11. Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes. Lehtonen A; Fodstad H; Laitinen-Forsblom P; Toivonen L; Kontula K; Swan H Heart Rhythm; 2007 May; 4(5):603-7. PubMed ID: 17467628 [TBL] [Abstract][Full Text] [Related]
12. Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome. Haraoka K; Morita H; Saito Y; Toh N; Miyoshi T; Nishii N; Nagase S; Nakamura K; Kohno K; Kusano KF; Kawaguchi K; Ohe T; Ito H Heart Rhythm; 2010 Dec; 7(12):1808-14. PubMed ID: 20837161 [TBL] [Abstract][Full Text] [Related]
13. Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death. Wolbrette DL Curr Cardiol Rep; 2004 Sep; 6(5):379-84. PubMed ID: 15306095 [TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study. Houltz B; Darpö B; Edvardsson N; Blomström P; Brachmann J; Crijns HJ; Jensen SM; Svernhage E; Vallin H; Swedberg K Pacing Clin Electrophysiol; 1998 May; 21(5):1044-57. PubMed ID: 9604236 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany. Sarganas G; Garbe E; Klimpel A; Hering RC; Bronder E; Haverkamp W Europace; 2014 Jan; 16(1):101-8. PubMed ID: 23833046 [TBL] [Abstract][Full Text] [Related]
16. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes. Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632 [TBL] [Abstract][Full Text] [Related]
17. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation. Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374 [TBL] [Abstract][Full Text] [Related]
18. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block. Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857 [TBL] [Abstract][Full Text] [Related]
19. Suppression of Torsades de Pointes by biventricular pacing in a patient with long QT syndrome. Miyoshi F; Tanno K; Kobayashi Y Pacing Clin Electrophysiol; 2013 Mar; 36(3):e67-9. PubMed ID: 22126601 [TBL] [Abstract][Full Text] [Related]
20. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome. Hoshino K; Ogawa K; Hishitani T; Isobe T; Etoh Y Pediatr Int; 2006 Apr; 48(2):112-7. PubMed ID: 16635167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]